Hitachi reclaims Summit gamma cameras
Hitachi Medical of Tokyo will use the RSNA meeting as a springboardin its plan to reenter the nuclear medicine market with directsales and marketing of digital gamma cameras it has manufacturedfor Summit Nuclear. Hitachi will describe the products as
Hitachi Medical of Tokyo will use the RSNA meeting as a springboardin its plan to reenter the nuclear medicine market with directsales and marketing of digital gamma cameras it has manufacturedfor Summit Nuclear. Hitachi will describe the products as works-in-progresson panels in its RSNA booth (SCAN 10/11/95).
Hitachi manufactured the single-head 1024RZ and the dual-headT-22 for Summit, which this year merged with Sopha Medical toform SMV (SCAN 6/21/95). SMV decided to deemphasize the Hitachi-madecameras in favor of systems of its own design.
Hitachi has updated the 1024RZ and T-22 cameras and is resubmittinga 510(k) application for them under the trade name SPECTRADigital.Hitachi is also planning to develop a digital variable-angle dual-headgamma camera for release next year.
In MRI, Hitachi will highlight enhancements to its Airis andStratis platforms, introduced at last year's meeting. A new softwarerelease for the open-configuration Airis and the MRP-7000 0.3-teslaconventional magnet will enable the use of new fast scanning andMR angiography packages. On the 1.5-tesla Stratis, Hitachi willshow phased-array coils and multishot echo-planar imaging as works-in-progress.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
